Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
- Conditions
- Interventions
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- BicycleTx Limited
- Target Recruit Count
- 956
- Registration Number
- NCT06225596
- Locations
- 🇫🇷
Service d'Oncologie Medicale - CHRU Besancon, Besançon, France
🇫🇷Institut Bergonie, Bordeaux Cedex, France
🇫🇷CHU Bordeaux - Hopital Saint-Andre, Bordeaux, France
Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression
- First Posted Date
- 2021-12-20
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- BicycleTx Limited
- Target Recruit Count
- 200
- Registration Number
- NCT05163041
- Locations
- 🇺🇸
State University of Iowa, Iowa City, Iowa, United States
🇺🇸Columbia University Irving Medical Center, New York, New York, United States
🇺🇸University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
- Conditions
- Interventions
- First Posted Date
- 2020-09-23
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- BicycleTx Limited
- Target Recruit Count
- 329
- Registration Number
- NCT04561362
- Locations
- 🇫🇷
Centre Eugene Marquis, Rennes, France
🇫🇷Institut Bergonie, Bordeaux, France
🇫🇷Institut Gustave Roussy, Villejuif, France
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
- First Posted Date
- 2019-11-27
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- BicycleTx Limited
- Target Recruit Count
- 288
- Registration Number
- NCT04180371
- Locations
- 🇺🇸
Sarah Cannon and HCA Research Institute, Nashville, Tennessee, United States
🇺🇸California Cancer Associates for Research and Excellence, Inc., Encinitas, California, United States
🇺🇸University of California, San Diego (UCSD) - Medical Center, La Jolla, California, United States